Objectives: In chronic obstructive pulmonary disease (COPD), quality of life and exercise capacity are altered in relationship to dyspnea. Benefits of inspiratory muscle training (IMT) on quality of life, dyspnea, and exercise capacity were demonstrated, but when it is associated to pulmonary rehabilitation (PR), its efficacy on dyspnea is not demonstrated. The aim of this systematic review with meta-analysis was to verify the effect of IMT using threshold devices in COPD patients on dyspnea, quality of life, exercise capacity, and inspiratory muscles strength, and the added effect on dyspnea of IMT associated with PR (vs. PR alone).
| B ACKG ROU ND
In chronic obstructive pulmonary disease (COPD), quality of life and exercise capacity are altered [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] in relationship to dyspnea. [12] [13] [14] [15] [16] Moreover, muscle weakness is frequent and contributes to exercise limitation. 17 When it concerns inspiratory muscles, it can increase dyspnea. [18] [19] [20] [21] [22] [23] As dyspnea is the main complaint in COPD patients, 1 its reduction is one of the most important aims of the treatment. Clinical efficacy regarding dyspnea alleviation must be targeted because it is related to treatment adherence. 24 Inspiratory muscle training (IMT) has been used for a long time. 25 Its benefits were demonstrated on quality of life, dyspnea, and exercise capacity [26] [27] [28] [29] and maintaining these benefits requires long term treatment. 30 IMT is effective alone or associated with pulmonary rehabilitation programs. [26] [27] [28] [29] However, when IMT is associated to pulmonary rehabilitation, its efficacy on dyspnea is not demonstrated.
The previous meta-analysis was written 7 years ago and it seems important to update these results with the studies published more recently because they focused on new topics (dyspnea) and they had a high internal quality and to improve the knowledge of benefits of IMT in COPD patients. Indeed, since this time, 11 studies were published and particularly during the last year.
The aim of this meta-analysis was to verify the effect of IMT using threshold devices in COPD patients on dyspnea, quality of life, exercise capacity, and inspiratory muscles strength, and the added effect on dyspnea of IMT associated with PR (vs. PR alone).
| M ETH OD
This systematic review was registered (PROSPERO registration number: CRD42015017638) and is reported according to the PRISMA guidelines. 31 
| Data sources and eligibility criteria
This systematic review was conducted on the databases from PubMed, Science direct, Cochrane library, Web of science, and Pascal. Following key words were used: inspiratory, respiratory, ventilatory, muscle, and training. They were applied on following disease conditions: pulmonary disease, chronic obstructive, chronic obstructive lung disease, chronic obstructive airway disease, and chronic obstructive pulmonary disease. The searching period extended from the database inception to December 2017. Eligibility criteria were availability of full texts in English or in French.
| Search
The search strategy used was as following: (inspiratory muscle training OR respiratory muscle training OR ventilatory muscle training) AND (pulmonary disease OR chronic obstructive OR chronic obstructive lung disease OR chronic obstructive airway disease OR chronic obstructive pulmonary disease). A filter based on the search period (01/01/ 0001-31/12/2017) was used.
| Inclusion criteria
Inclusion criteria were: studies evaluating short and long term effects of inspiratory muscle training with a threshold device in stable or experiencing acute exacerbation COPD patients. Studies had to include one of these outcomes: dyspnea, quality of life, exercise capacity, and maximal inspiratory pressure (PImax). Randomized controlled trials (RCT), non-randomized controlled trials (CT), and cohort studies were included in this review.
Sample size and lack of control group were not exclusion criteria. Title and abstract were reviewed by two investigators (MB, GR) to identify potential relevant articles. Disagreements were resolved by consensus or discussion with a third investigator.
| Study selection and data collection process
Each study was critically and independently appraised by two investigators (MB and GR) for the following components: sample size, patient's characteristics and lung function, intervention (duration, frequency, intensity, and used device), comparison, summary of the results, strength, and limits of the study. Risk ratio and mean comparison and adherence/completion level were reported. The GRADE system was used to assess the quality of a body of evidence for each individual outcome. 32 The internal validity of the randomized (controlled and cross-over) studies and observational studies was evaluated using the Physiotherapy Evidence Database (PEDro) scale and the Downs and Black tool, 33 respectively.
| Statistical analysis
The outcomes were isolated from the studies identified as described above. To analyze the mean differences, the fixed-effect analysis model for continuous outcomes was used.
We analyzed the studies according to initial level of PImax (PImax > or 60 cm H 2 O), on the basis of the existing literature and recommendations. Data are presented as mean, with their 95% confidence intervals. Heterogeneity was assessed by the I 2 statistics for each comparison. An I 2 > 40% was considered to reject the homogeneity of the comparison (and to accept heterogeneity hypothesis). In the cases of heterogeneity, a random-effect model was used. For all the comparisons, a P value <.05 was considered as statistically significant. All the analyses were done using RevMan 5.3 (the Cochrane Collaboration, Oxford, UK).
| RES U LTS
Two thousand and fifty-seven articles were identified but only 43 studies (38 RCT, 2 CT, and 3 cohort studies)
were included in the systematic review and 37 out of them in the meta-analysis. Reasons for study exclusion are outlined in Figure 1 . 31 The characteristics of included studies are described in Table S1 (see in Supporting Information).
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| Description of studies
One thousand forty hundred and twenty-seven patients were included in these studies and overall treatment group consisted of six hundred and forty-two patients.
Description of IMT programs is outlined in Table S1 (see in Supporting Information). Frequency of IMT was 5 days a week for 32 studies and 2 days a week in one study. Duration of the training ranged from 1 week to 1 year and intensity of IMT varied from 30% to 80% of maximal inspiratory pressure (PImax).
IMT was used alone in 79% of the studies or associated with general exercise training. When IMT was used alone, it was compared with sham IMT, general exercise training, incentive spirometry, education, respiratory muscle stretch gymnastics, expiratory muscle training, and usual care. IMT was also associated with pulmonary rehabilitation and compared with usual care. In one non-randomized controlled trial, four groups were studied: IMT 1 pulmonary rehabilitation; expiratory muscle training (EMT) 1 pulmonary rehabilitation; IMT 1 EMT 1 pulmonary rehabilitation; pulmonary rehabilitation alone (control group).
Methodological quality score varied from 3 to 8/10 according to PEDro score for the RCT and from 11 51 to 12 36 according to Downs and Black scale 33 for the other studies.
| Outcomes
The results of effects of IMT according to the different outcomes are mentioned in Table S2 (see in Supporting Information).
| Dyspnea
Twenty-three studies used dyspnea as outcome. Borg scale or modified Borg Scale, Visual Analogic Scale (VAS), Baseline-Transition Dyspnea Index (BDI-TDI), Multidimensional Dyspnea Profile questionnaire (MDP), and item dyspnea of Chronic Respiratory Questionnaire (CRQ) were used to evaluate dyspnea.
Borg scale and VAS were used to evaluate dyspnea at the end of the 6MWT, at the end of incremental or constant load test or during IMT session; the decrease of dyspnea was not significant but trends toward a significant decrease (Figure 2 ). Patients without weakness of inspiratory muscles had a significant decrease of dyspnea.
Using BDI-TDI, the decrease of dyspnea was significant ( Figure 3 ). There was no difference according to level of PImax.
F IGUR E 2 Effects of inspiratory muscle training on dyspnea (Borg scale)
F IGUR E 3 Effects of inspiratory muscle training on dyspnea (BDI-TDI) BEAUMONT ET AL.
|
Using item dyspnea of CRQ, the decrease of dyspnea was clinically relevant (more than 0.5 point).
In the non-randomized controlled trial, 36 dyspnea was decreased after the program independently on the group (control and treatment) and it was systematically clinically relevant (more than one point of reduction on the MMRC scale).
76
IMT and general exercise training reduced dyspnea after 4 and 8 weeks, but reduction of dyspnea at the end of the 6MWT was not significant compared with baseline in IMT group, whereas it was significant in the general physical training group. 37 The decrease of dyspnea was clinically significant according to the minimal clinical important difference (MCID) described by Crisafulli (one point reduction with VAS) 76 only for general physical training group. 67 However, the decrease of dyspnea was almost clinically significant only for the IMT group, at the end of the incremental exercise test (20.8 point).
37
Dyspnea during constant and incremental load tests was significantly decreased with IMT alone compared with the control group reaching the clinical relevance only for the constant load test (two points reduction with the modified Borg scale). 67 The decrease of dyspnea between the two groups (CET group vs. CET 1IMT group) was not different. 75 Dyspnea at the end of 6MWT was decreased in all studies 36, 44, 61, 64, 66, 72, 74 but was clinically relevant in only two studies. 36, 61 Dyspnea during or at the end of IMT session was clinically relevant (>2 points on Borg Scale) in all studies. 34, 40, 62 During PR, five authors used dyspnea as outcome. 36, 44, 47, 59, 74 In all studies, dyspnea was decreased after PR program with or without IMT. In four studies, 44 ,47,59,74 the authors founded no difference between groups for improvement in dyspnea and in the last study, 36 groups were not compared.
| Quality of life
Nine studies used quality of life as outcome. Saint George's Respiratory Questionnaire (5 studies) or CRQ (3 studies) or Short Form 236 quality of life questionnaire (SF-36) (1 study) were used to assess quality of life.
The results of the meta-analysis just failed to reach statistical significant improvement of quality of life using SGRQ (Figure 4 ) or CRQ ( Figure 5 ).
The authors of all studies without one study 74 reported relevant improvement (reduction of at least four points in SGRQ or increase of more than 0.5 per item of CRQ). 77 
| Exercise capacity
Thirty-three studies assessed exercise capacity with different tools: 6 min walk test (6MWT) (22 studies), 12MWT (5 studies), incremental shuttle walk test (ISWT) (3 studies), or Cardio Pulmonary Exercise Test (CPET) (5 studies). IMT improved significantly walked distance during 6MWT and the improvement was clinically important (143 m) ( Figure 6 ).
Using ISWT or 12MWT, IMT improved exercise capacity but the improvement was not significant Using CPET, four studies 38, 61, 69, 75 showed improvement and a study a decrease in maximal workload.
59
F IGUR E 4 Effects of inspiratory muscle training on quality of life (SGRQ)
| Inspiratory muscle strength
Only 2 out of 43 studies did not evaluate PImax. 46, 63 PImax increased systematically after IMT training (Table  S2 ) (see in Supporting Information). The increase of PImax after IMT is significant compared with Control group (Figure 7 ).
| DI S CU S S IO N
The purpose of this review was to evaluate effects of IMT using threshold device on dyspnea, quality of life, exercise capacity, and inspiratory muscle strength in COPD patients.
F IGUR E 6 Effects of inspiratory muscle training on exercise capacity (6MWD)
F IGUR E 5 Effects of inspiratory muscle training on quality of life (CRQ)
|
We choose to include only studies which use constant load threshold for IMT, as it was recommended. 24 Eight randomized controlled trials and one non randomized controlled trial using threshold device for IMT were published since the last meta-analysis by Gosselink et al. in 2011 whereas the need for studies was clearly mentioned. 29 Frequency and intensity are variables depending on the studies from two times per week to seven times per week and from 30 to 80% of PImax, respectively. It highlights the lack of clear recommendations on IMT program's modalities, even if Gloeckl et al. give practical recommendations for the implementation of IMT during pulmonary rehabilitation. 78 The methodological quality of analyzed studies is moderate (for 23 studies) to high (15 randomized controlled trial), using Pedro scale. High methodological quality trials are necessary for improving evidence based on IMT.
This meta-analysis showed that IMT improve dyspnea compared with control group using BDI-TDI and the improvement is clinically relevant. Two previous metaanalysis compared IMT with exercises training but dyspnea was not included as outcome due to the lack of data related to this outcome at this time. 79, 80 Petrovic et al. 67 evaluated effects of IMT on inspiratory capacity (IC) and inspiratory fraction (IC/TLC) which are two clinical parameters reflecting hyperinflation. They demonstrated that in comparison with usual care, IMT improved more hyperinflation which is an important mechanism explaining dyspnea in COPD. [14] [15] [16] [81] [82] [83] [84] It provides a novel and interesting hypothesis about the mechanisms explaining efficacy of IMT on dyspnea. However, benefit of IMT on dyspnea seems less important with IMT than with physical training. 41, 48 The added benefit of IMT on dyspnea for patients with F IGUR E 7 Effects of inspiratory muscle training on maximal inspiratory strength (PImax) inspiratory muscle weakness (PImax 60 cm H 2 O) was not verified. Then the initial level of PImax seems to be not a good predictor, whereas it is recommended, but the level of initial breathlessness should be more appropriated, as it was already suggested in the previous meta-analysis. Since 1996, four randomized trials 44, 47, 59, 74 and one controlled trial 36 evaluated benefit on dyspnea of adding IMT to pulmonary rehabilitation. In all studies, dyspnea was decreased after PR program with or without IMT. In four studies, 44, 47, 59, 74 the authors founded no difference between groups for improvement in dyspnea and in the last study, 36 groups were not compared. These results show the lack of added benefit of IMT to PR (vs. PR alone) on subjective parameters such as dyspnea. A study in progress is investigating the benefit of IMT combination to general exercise training program. 85 According to the ATS/ERS task force, 9 further studies are needed to investigate added benefits of IMT on dyspnea, during a pulmonary rehabilitation program.
Since the last meta-analysis, 29 only three randomized trial 63, 71, 74 evaluated effects of IMT on quality of life even though the quality of life improvement is a major objective for patients with chronic disease. Quality of life was significantly and clinically improved with IMT compared with control in two studies. 63, 71 This clinical benefit is important to promote a better observance to the treatment and to maintain motivation. Moreover, it was suggested by Gosselink et al. using IMT at long term is one of challenges of this treatment to sustain benefits as quality of life.
29
In a study about ground based walking training, Wooton et al. 86 showed clinical benefits with such a training after eight weeks (six points improvement in SGRQ) compared with usual care. Another study 87 reported clinical benefits after a 12-weeks whole-body vibration training (>10 points improvement in SGRQ). These results are comparable those obtained with IMT. About exercise capacity, IMT improves walk distance during 6MWT with clinical relevant increase. We did not found difference according to initial level of PImax.
However, compared with general exercise program, IMT seems not beneficial. It confirms previous systematic reviews. 79, 80 Although Cooper showed a 23 m improvement in walked distance during 6MWT after IMT but it is lower than the minimal clinical important difference, 88, 89 contrarily to the improvement (32 m) observed in the physical training group. Benzo 46 found no improvement in exercise capacity after IMT but it can be nuanced by the short duration of the program. Beaumont et al. 44 and Wang et al. 74 found no difference between groups for exercise capacity. Indeed, duration of the other programs varied between four and eight weeks. We can hypothesize that, similarly to pulmonary rehabilitation, 9 longer the program, better the benefit.
Our meta-analysis highlighted that PImax improves with IMT in COPD patients (independently on the inspiratory muscle weakness) even if heterogeneity of the studies was important. However, sensitivity analyses were performed but did not change significantly the results. Improvement ranged from 2.5 to 93.7% (median: 25 [18-34.75] ). By comparison with other respiratory disease (as asthma or cystic fibrosis), 90, 91 this improvement in PImax after IMT is similar whereas in chronic heart failure 92 improvement appears more important. To our knowledge, no MCID is determining for PImax. It means that the clinical significance of this effect is difficult to interpret. Then to determine a MCID is an important objective in futures studies. For patients, PImax improvement alone does not seem to be important for them. So, correlate PImax with clinical outcome could be interesting for improving motivation for IMT.
| CON CLU S IO N
IMT improves inspiratory muscle strength, quality of life (SGRQ), and exercise capacity (6MWT), decreases dyspnea (BDI-TDI). There is no added effect of IMT on dyspnea during PR, compared with PR alone. Level of initial PImax did not seem to affect results. However, effects of IMT on dyspnea and quality of life have to be more investigated. Moreover, studies are necessary to determine the optimal settings for IMT and MCID related to PImax. Particular attention should be paid to the association of IMT with pulmonary rehabilitation.
SUPPORTING INFORMATION
Additional supporting information may be found online in the Supporting Information section at the end of the article. 
